SUBSCRIBE TO PE HUB WIRE
Join over 70,000 of your peers
Get the must-read email for PE/VC professionals delivered to your inbox daily
— for free!
Stelexis Therapeutics procures $43 mln Series A
New York-based Stelexis Therapeutics, a cancer therapeutics firm, has secured $43 million in Series A financing. Stelexis is backed by Deerfield.
Source: Press Release
PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.
Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!